| Metric | Current Period | Same Period Last Year | YoY |
|---|---|---|---|
| Revenue | ¥263.2B | ¥242.9B | +8.3% |
| Operating Income | ¥20.6B | ¥15.0B | +37.1% |
| Ordinary Income | ¥24.1B | ¥18.1B | +33.4% |
| Net Income | ¥16.6B | ¥11.9B | +39.9% |
| ROE | 1.9% | 1.4% | - |
FY2027 Q1 delivered higher revenue and higher earnings, with operating leverage from an improved gross margin and lower SG&A ratio driving performance. Revenue was ¥263.2B (¥242.9B in the same period last year, YoY +8.3%), Operating Income was ¥20.6B (+37.1%), Ordinary Income was ¥24.1B (+33.4%), and Net Income was ¥16.6B (+39.9%; Net Income attributable to owners of the parent was ¥16.5B, +39.6%). Revenue growth was primarily driven by a +28.4% increase in the Chemicals Business, while earnings growth was supported by a decline in the SG&A ratio to 19.8% (21.2% in the same period last year) and improved profitability in the Chemicals Business.
【Revenue】Revenue was ¥263.2B (YoY +8.3%). The core Gas Business, which accounted for 69.3% of total revenue, maintained steady growth at ¥182.3B (+2.4%), while the Chemicals Business led company-wide growth with revenue of ¥71.3B (+28.4%). The Other Businesses recorded ¥9.5B (+1.8%), representing only modest revenue growth.
【Profit and Loss】Operating Income was ¥20.6B (YoY +37.1%), and the Operating Income margin improved to 7.8% from 6.2% in the same period last year, an improvement of +165bp. The gross margin edged up to 27.6% from 27.3%, while the SG&A ratio declined to 19.8% from 21.2%, providing operating leverage. By segment, Gas generated ¥16.6B in profit (-1.0%; profit margin of 9.1%), remaining broadly flat, whereas Chemicals recorded ¥8.7B (+258.4%; profit margin of 12.2%), a substantial improvement that contributed to the increase in company-wide profit. Ordinary Income was ¥24.1B (+33.4%), supported by ¥4.4B in non-operating income, including ¥1.6B in dividend income and ¥0.6B in foreign exchange gains. Net Income was ¥16.6B (+39.9%) after ¥7.5B in income taxes and other taxes (an effective tax rate of approximately 31.0%). Revenue and earnings both increased.
The Gas Business recorded revenue of ¥182.3B (+2.4%) and profit of ¥16.6B (-1.0%), with a profit margin of 9.1%; despite its scale, its earnings growth momentum slowed. The Chemicals Business recorded revenue of ¥71.3B (+28.4%) and profit of ¥8.7B (+258.4%), with a profit margin of 12.2%, a substantial improvement that exceeded the Gas Business’s profit margin. Improved product mix and price adjustments are believed to be the underlying factors. The Other Businesses recorded revenue of ¥9.5B (+1.8%) and an Operating Loss of ¥0.3B, deteriorating from a loss of ¥0.2B in the same period last year, indicating continued weak profitability. Revenue composition was 69.3% Gas, 27.1% Chemicals, and 3.6% Other, while Gas and Chemicals represented nearly two main pillars in terms of profit.
【Profitability】The Operating Income margin improved to 7.8% from 6.2% in the same period last year, while the Net Income margin improved to 6.3% from 4.9%. The primary factors were the increase in the gross margin to 27.6% and the decline in the SG&A ratio to 19.8%. 【Cash Flow Quality】Accounts receivable of ¥174.2B and inventories of ¥39.1B have accumulated at a faster pace than revenue growth, suggesting that the speed of asset monetization may not be keeping pace with business growth. 【Investment Efficiency】ROE was 1.9%, while total assets were ¥1256.8B, leaving the total asset turnover ratio at a low level; the company’s asset intensity is constraining capital efficiency. 【Financial Soundness】The Equity Ratio was high at 69.1%, and current assets of ¥618.6B substantially exceeded current liabilities of ¥277.6B, indicating a strong financial foundation.
Although the company did not disclose a statement of cash flows, changes in the balance sheet provide insight into cash movements. Cash and deposits were ¥268.1B, a slight decrease from just under ¥270B in the same period last year, while inventories increased by +12.4% YoY and investment securities increased by +11.8%, suggesting that funds may have been directed toward inventory and investments. Meanwhile, the Equity Ratio remained high at 69.1%, and cash and deposits of ¥268.1B compared with long-term borrowings of ¥52.8B indicate a substantial financial safety buffer. Given accounts receivable of ¥174.2B and inventories of ¥39.1B, there is room to improve the collection cycle for funds generated from operating activities, which will be an area to monitor when assessing future cash-generation capacity.
A high proportion of current-period profit was generated from recurring business activities. Extraordinary income was ¥0.1B, immaterial relative to Net Income, indicating that the impact of temporary factors was negligible. Of the ¥4.4B in non-operating income, the main components were ¥1.6B in dividend income and ¥0.6B in foreign exchange gains. Since both arose from factors outside the core business, their contribution could reverse depending on changes in foreign exchange market conditions. The difference between Ordinary Income of ¥24.1B and Net Income of ¥16.6B was attributable to ¥7.5B in income taxes and other taxes, resulting in an effective tax rate of approximately 31.0%, a standard level. Operating Income growth was supported by structural improvements in the gross margin and SG&A ratio, indicating a low degree of dependence on temporary factors.
Progress against the full-year forecast was 26.0% for Revenue (¥263.2B/¥1,010B), 34.9% for Operating Income (¥20.6B/¥59.0B), and 34.4% for Ordinary Income (¥24.1B/¥70.0B), with the profit items exceeding the 25% benchmark based on simple progress. There were no revisions to either the quarterly earnings forecast or the dividend forecast, and management has not changed its full-year outlook at this time. Since progress on earnings has exceeded revenue progress, SG&A ratio improvements and margin expansion in the Chemicals Business may be proceeding more rapidly than expected.
The company’s annual dividend forecast is ¥40, an increase from the previous year’s annual dividend (the total of the interim and year-end dividends, which was in the ¥20 range based on the prior-year benchmark). The Payout Ratio against forecast EPS of ¥83.32 is approximately 48%. Considering the financial foundation of an Equity Ratio of 69.1% and cash and deposits of ¥268.1B, the sustainability of the dividend is considered high. There has been no disclosure regarding share repurchases, and shareholder returns are centered on dividends.
Segment concentration risk: The Gas Business accounts for 69.3% of Revenue, creating a structure in which demand fluctuations and the success or failure of passing through prices in this business have a significant impact on company-wide performance.
Working capital tied up: Accounts receivable of ¥174.2B and inventories of ¥39.1B have both increased from the same period last year. Asset accumulation exceeding the pace of revenue growth could delay cash conversion.
Risk of reversal in non-operating income: Foreign exchange gains of ¥0.6B and dividend income of ¥1.6B, which boosted Ordinary Income, depend on market conditions. Their contribution could diminish depending on future foreign exchange trends.
Profitability and Return
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income margin | 7.8% | 8.7% (4.2%–14.2%) | -0.9pt |
| Net Income margin | 6.3% | 7.0% (3.2%–10.6%) | -0.7pt |
Both the Operating Income margin and Net Income margin were slightly below the industry median, placing profitability at a mid-range level.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue growth rate (YoY) | 8.3% | 6.2% (-1.1%–14.6%) | +2.1pt |
The Revenue growth rate exceeded the industry median, placing the company in a relatively favorable position in terms of growth.
Source: Company analysis
The margin of the Chemicals Business improved to 12.2%, exceeding the Gas Business’s 9.1%. This is a notable feature of the earnings data indicating progress toward diversification of the earnings structure.
Full-year progress was 34.9% for Operating Income and 34.4% for Ordinary Income, substantially exceeding the 25% benchmark based on simple progress, confirming a tendency for profit recognition to be weighted toward the first half.
The pace of growth in accounts receivable and inventories exceeded revenue growth, making changes in asset efficiency an item that should be monitored continuously in future earnings results.
This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson type with an explicit five-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥1,379 |
| base | ¥1,405 |
| bull | ¥1,416 |
| Calculation Assumption | Value |
|---|---|
| Book Value Per Share (BPS) | ¥1,574 |
| Adjusted Forecast EPS | ¥91.7 |
| Cost of Equity r | 9.77% (10-year government bond 2.77% + equity risk premium 6.00% + size premium 1.00%) |
| Residual income persistence factor ω / Explicit forecast period | 0.62 / 5 years |
| Assumed Payout Ratio | 48.0% |
| Forecast EPS confidence adjustment | ×1.100 (based on progress ahead of the full-year forecast) |
| implied PBR / PER | 0.89x / 15.3x |
Sensitivity: ¥1,367–¥1,445 at ±1% for the cost of equity, and ¥1,400–¥1,409 at ±0.1 for ω.
Notes:
(Model: Residual Income Model / Interest rate reference month: 2026-07 / This value does not forecast or guarantee the future share price.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings flash report data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, and you should consult a professional as necessary.
---End of Report---
These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.